{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:05:58Z","timestamp":1783717558849,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00520-010-0851-8","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T01:09:36Z","timestamp":1269392976000},"page":"545-554","source":"Crossref","is-referenced-by-count":40,"title":["Skin care management in cancer patients: an evaluation of quality of life and tolerability"],"prefix":"10.1007","volume":"19","author":[{"given":"Ann Cameron","family":"Haley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Calahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"issue":"7","key":"851_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1548-5315(11)70476-4","volume":"5","author":"M Lacouture","year":"2008","unstructured":"Lacouture M, West D, Tigue C, Knox K, Bennett C (2008) Cutaneous toxicities of targeted cancer therapies. Community Oncology 5(7):413\u2013414","journal-title":"Community Oncology"},{"issue":"3","key":"851_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00520-007-0318-8","volume":"16","author":"M Hackbarth","year":"2008","unstructured":"Hackbarth M, Haas N, Fotopoulou C, Lichtenegger W, Sehouli J (2008) Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study. Support Care Cancer 16(3):267\u2013273","journal-title":"Support Care Cancer"},{"key":"851_CR3","first-page":"1","volume":"20","author":"P O'Keeffe","year":"2006","unstructured":"O'Keeffe P, Parrilli M, Lacouture M (2006) Toxicity of targeted therapy: focus on rash and other dermatologic side effects. Oncol Nurses Ed 20:1\u20136","journal-title":"Oncol Nurses Ed"},{"issue":"11 Suppl 5","key":"851_CR4","first-page":"34","volume":"21","author":"L Wagner","year":"2007","unstructured":"Wagner L, Lacouture M (2007) Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology (Williston Park) 21(11 Suppl 5):34\u201336","journal-title":"Oncology (Williston Park)"},{"key":"851_CR5","unstructured":"Gandhi M, Oishi K, Zubal B. Unanticipated toxicities from anti-cancer therapies: survivors\u2019 perspectives.Support Care in Cancer (in press)"},{"issue":"7","key":"851_CR6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archderm.144.7.886","volume":"144","author":"J Autier","year":"2008","unstructured":"Autier J, Escudier B, Wechsler J, Spatz A, Robert C (2008) Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol 144(7):886\u2013892","journal-title":"Arch Dermatol"},{"issue":"6","key":"851_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1524-4741.2007.00512.x","volume":"13","author":"L Richardson","year":"2007","unstructured":"Richardson L, Wang W, Hartzema A, Wagner S (2007) The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast J 13(6):581\u2013587","journal-title":"Breast J"},{"issue":"3","key":"851_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","volume":"40","author":"W Susser","year":"1999","unstructured":"Susser W, Whitaker-Worth D, Grant-Kels J (1999) Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 40(3):367\u2013398, quiz 99-400","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"851_CR9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1634\/theoncologist.12-5-610","volume":"12","author":"T Lynch","year":"2007","unstructured":"Lynch T, Kim E, Eaby B, Garey J, West D, Lacouture M (2007) Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 12(5):610\u2013621","journal-title":"Oncologist"},{"issue":"3","key":"851_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.soncn.2006.04.004","volume":"22","author":"M McQuestion","year":"2006","unstructured":"McQuestion M (2006) Evidence-based skin care management in radiation therapy. Semin Oncol Nurs 22(3):163\u2013173","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"851_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00520-006-0063-4","volume":"14","author":"A Bolderston","year":"2006","unstructured":"Bolderston A, Lloyd N, Wong R, Holden L, Robb-Blenderman L (2006) The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer 14(8):802\u2013817","journal-title":"Support Care Cancer"},{"key":"851_CR12","unstructured":"Lindi\u00aeSkin (2008) http:\/\/lindiskin.com\/"},{"key":"851_CR13","unstructured":"CTC v2.0 and common terminology criteria for adverse events v3.0 (CTCAE). (2009) http:\/\/ctep.cancer.gov\/reporting\/index.html"},{"issue":"2","key":"851_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02737863","volume":"5","author":"M Chren","year":"2001","unstructured":"Chren M, Lasek R, Sahay A, Sand L (2001) Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 5(2):105\u2013110","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"851_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris M et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903\u2013909","journal-title":"Lancet Oncol"},{"issue":"3","key":"851_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1473-2165.2006.00261.x","volume":"5","author":"T Weber","year":"2006","unstructured":"Weber T, Ceilley R, Buerger A, Kolbe L, Trookman N, Rizer R et al (2006) Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A. J Cosmet Dermatol 5(3):227\u2013232","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"851_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","volume":"6","author":"C Robert","year":"2005","unstructured":"Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P et al (2005) Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 6(7):491\u2013500","journal-title":"Lancet Oncol"},{"issue":"1","key":"851_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jnci\/djp439","volume":"102","author":"RE Eilers Jr","year":"2010","unstructured":"Eilers RE Jr, Gandhi M, Patel JD, Mulcahy MF, Agulnik M, Hensing T et al (2010) Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer Inst 102(1):47\u201353","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"851_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1008806828316","volume":"8","author":"D Fairclough","year":"1999","unstructured":"Fairclough D, Fetting J, Cella D, Wonson W, Moinpour C (1999) Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG). Qual Life Res 8(8):723\u2013731","journal-title":"Qual Life Res"},{"issue":"5","key":"851_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejon.2007.03.002","volume":"11","author":"H Frith","year":"2007","unstructured":"Frith H, Harcourt D, Fussell A (2007) Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer. Eur J Oncol Nurs 11(5):385\u2013391","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"851_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1037\/0022-006X.59.4.518","volume":"59","author":"T Burish","year":"1991","unstructured":"Burish T, Snyder S, Jenkins R (1991) Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol 59(4):518\u2013525","journal-title":"J Consult Clin Psychol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00520-010-0851-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T02:29:05Z","timestamp":1497839345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-0851-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-0851-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,25]]}}}